Table 5 Co-morbid conditions present in QFT negative study subjects
Subjects with Active TB (n = 20) | |||||
|---|---|---|---|---|---|
Co-morbids | Frequency (n, %) | TB Ag (IFNγ IU/ml, Median) | Mitogen (IFNγ IU/ml, Median) | TLC (%) | Lymphocytes (%) |
None known | 12 (60) | 0.025 | 10 | 8.1 | 18.2 |
Diabetes | 3 (15) | 0.07 | 5.79 | 8.1 | 19.4 |
Other Endo | 1 (5) | 0.03 | 8.27 | 13.2 | 19 |
Auto immune diseasea | 1 (5) | 0.01 | 1.85 | 10.7 | 15.9 |
Malignancy | 1 (5) | 0.04 | 0.77 | 109 | 1 |
CHD | 1 (5) | 0.01 | 10 | 7 | 32 |
Multiple Co-morbidsb | 1 (5) | 0.1 | 4.08 | 7.7 | 17.7 |
Subjects with Non-TB (n = 73) | |||||
Co-morbids | Frequency (n, %) | TB Ag (IFNγ IU/ml, Median) | Mitogen (IFNγ IU/ml, Median) | TLC (%) | Lymphocytes (%) |
None known | 24 (33) | 0.025 | 10 | 7.4 | 23.6 |
Chronic Kidney Disease | 7 (10) | 0.04 | 8.15 | 7.8 | 20.6 |
Chronic Lung Disease | 3 (4) | 0.04 | 7.66 | 5.8 | 17.9 |
Diabetes | 10 (14) | 0 | 7.81 | 11 | 11.8 |
Auto Immune diseasea | 6 (8) | 0.01 | 10 | 9.4 | 17 |
Malignancy | 10 (14) | 0.065 | 6.88 | 8.1 | 23.5 |
Epilepsy | 1 (1) | 0.03 | 10 | 5.8 | 38.4 |
Coronary Heart Disease | 1 (1) | 0 | 4.29 | 24.4 | 12 |
Multiple co-morbids | 11 (15) | 0 | 10 | 36 | 21.3 |